Elman Retina Group, PA

Baltimore, Maryland 21237

2 studies enrolling now · 33 studies all time

What they study most

AMD - Age-Related Macular Degeneration, Age Related Macular Degeneration, Central Retinal Vein Occlusion, Diabetes, Diabetic Macular Edema, Diabetic Retinopathy, Epiretinal Membrane, Geographic Atrophy, Intermediate Age Related Macular Degeneration (Disorder), Macular Telangiectasia Type 2, Neovascular Age-related Macular Degeneration, Panuveitis

Studies at this site

• Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR — Recruiting now
• Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM — Recruiting now
• Fenofibrate for Prevention of DR Worsening — Running, not enrolling
• A Study of NGM621 in Participants With Geographic Atrophy — Completed
• NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME) — Completed
• A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol B — Completed
• Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration — Completed
• Anti-VEGF Treatment for Prevention of PDR/DME — Completed
• Evaluation of Repeated, In-Clinic, Self-Imaging by DME Patients Using the Notal Vision Home OCT — Status unconfirmed
• Effects of Pneumatic Vitreolysis on Vitreomacular Traction — Completed
• A Pilot Study Evaluating Photobiomodulation Therapy for Diabetic Macular Edema — Completed
• Single In-Clinic Encounter With the Notal Vision Home OCT — Completed
• Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy — Completed
• Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) — Completed
• Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis — Completed
• Anti-VEGF vs. Prompt Vitrectomy for VH From PDR — Completed
• NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients — Completed
• PROMINENT-Eye Ancillary Study (Protocol AD) — Stopped early
• Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema — Completed
• Treatment for CI-DME in Eyes With Very Good VA Study — Completed
• Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema — Completed
• Evaluation of Vitrectomy for Diabetic Macular Edema — Completed
• HOme Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome Device — Completed
• Phase II Combination Steroid and Anti-VEGF for Persistent DME — Completed
• Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial — Completed
• Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema — Completed
• A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin) — Completed
• Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control — Completed
• Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) — Completed
• Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy — Completed
• The Course of Response to Focal Photocoagulation for DME — Completed
• Ocriplasmin Research to Better Inform Treatment (ORBIT) — Completed
• Squalamine for the Treatment in Proliferative Diabetic Retinopathy — Completed